1179624

Loxo Oncology, Inc. — FEI 3021192612

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 9, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
South San Francisco, CA (United States)

Additional Details

Sponsor, Contract Research Organization